At-Home Drug Delivery of Large Molecule Medicines - The Future Is Now
Current large volume drug delivery methods generally require the patient and provider to be in the clinic. However, the desire to treat patients outside the clinic is growing, not only in the era of COVID-19, but also as treatment durations grow and disease is caught earlier. For drug developers invested in early and chronic disease areas such as oncology, respiratory disease, or neuroscience, convenient drug delivery is a brand necessity. Dosing outside the clinic has traditionally been challenging. But new delivery technologies are facilitating this possibility, leading to improved patient compliance and better outcomes.
Join in the revolution in drug delivery convenience as Pharma leaders, a KOL, and an innovator discuss technologies that can aid at-home patient-administered drug delivery – and how improving patient convenience can result in product differentiation and revenue growth.
This webinar is intended for Commercial, R&D, and CMC biopharmaceutical leaders.
enFuse®, developed and manufactured by Enable Injections, is an investigational device, limited by United States law to investigational use.
Elizabeth Shaheen Patient Convenience Advocate, Biopharma Strategist
Jim Collins Drug Delivery Device Expert
Mike Hooven CEO, Enable Injections
Dr. Len Lichtenfeld Chief Medical Officer, Jasper Health
Date: Wednesday, March 23, 2022 Time: 11am ET / 8am PT Duration: 1 Hour